Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis

Zoledronic acid is used to treat patients with bone metastasis, but the optimal dosing interval remains controversial. We therefore performed a systematic review and meta-analysis to compare the efficacy and safety of a 12-week interval of zoledronic acid with the standard 4-week interval. Three ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ling, Yang, Yong-Jing, Diao, Jian-Dong, Zhang, Xu-He, Liu, Yan-Ling, Wang, Bo-Yu, Li, Zhi-Wen, Liu, Shi-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685751/
https://www.ncbi.nlm.nih.gov/pubmed/29163830
http://dx.doi.org/10.18632/oncotarget.19856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685751/
https://www.ncbi.nlm.nih.gov/pubmed/29163830
http://dx.doi.org/10.18632/oncotarget.19856

Ejemplares similares